Cara Therapeutics Inc (CARA)
0.69
-0.04
(-5.72%)
USD |
NASDAQ |
Apr 18, 16:00
0.70
+0.01
(+1.45%)
After-Hours: 20:00
Cara Therapeutics Market Cap: 37.71M for April 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 37.71M |
| April 17, 2024 | 40.00M |
| April 16, 2024 | 38.75M |
| April 15, 2024 | 38.81M |
| April 12, 2024 | 41.76M |
| April 11, 2024 | 44.30M |
| April 10, 2024 | 44.38M |
| April 09, 2024 | 45.47M |
| April 08, 2024 | 45.12M |
| April 05, 2024 | 47.80M |
| April 04, 2024 | 45.14M |
| April 03, 2024 | 49.60M |
| April 02, 2024 | 50.26M |
| April 01, 2024 | 49.74M |
| March 28, 2024 | 49.74M |
| March 27, 2024 | 47.50M |
| March 26, 2024 | 39.91M |
| March 25, 2024 | 44.81M |
| March 22, 2024 | 48.28M |
| March 21, 2024 | 48.73M |
| March 20, 2024 | 49.34M |
| March 19, 2024 | 48.64M |
| March 18, 2024 | 49.60M |
| March 15, 2024 | 47.99M |
| March 14, 2024 | 42.99M |
| Date | Value |
|---|---|
| March 13, 2024 | 47.56M |
| March 12, 2024 | 48.10M |
| March 11, 2024 | 51.92M |
| March 08, 2024 | 53.64M |
| March 07, 2024 | 57.39M |
| March 06, 2024 | 54.12M |
| March 05, 2024 | 49.74M |
| March 04, 2024 | 54.65M |
| March 01, 2024 | 51.92M |
| February 29, 2024 | 46.32M |
| February 28, 2024 | 48.49M |
| February 27, 2024 | 51.51M |
| February 26, 2024 | 43.64M |
| February 23, 2024 | 49.42M |
| February 22, 2024 | 43.52M |
| February 21, 2024 | 36.84M |
| February 20, 2024 | 34.99M |
| February 16, 2024 | 34.12M |
| February 15, 2024 | 32.43M |
| February 14, 2024 | 30.79M |
| February 13, 2024 | 29.05M |
| February 12, 2024 | 31.76M |
| February 09, 2024 | 30.83M |
| February 08, 2024 | 28.34M |
| February 07, 2024 | 29.00M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
28.34M
Minimum
Feb 08 2024
1.460B
Maximum
Apr 09 2021
595.92M
Average
652.73M
Median
Dec 20 2021
Market Cap Benchmarks
| Nektar Therapeutics | 242.38M |
| Stereotaxis Inc | 201.22M |
| Cerus Corp | 298.21M |
| Avid Bioservices Inc | 412.95M |
| Rigel Pharmaceuticals Inc | 184.15M |
Market Cap Related Metrics
| PS Ratio | 1.782 |
| PEG Ratio | -0.0083 |
| Price to Book Value | 0.6606 |
| Price | 0.69 |
| Earnings Yield | -317.4% |
| PEGY Ratio | -0.0083 |